Turbo Pad for The Pacey Cuff

TURBO PAD

Pacey Medtech gets feedback regarding fitting issues from users of the Pacey Cuff. This feedback often reflects difficulty that users are having with fitting the device. The great feature of the Pacey Cuff is its growing flexibility as the company understands the issues noted by customers.

                        The following tips are suggested.

1. The Goal of use of the Pacey Cuff is to apply correct pressure levels to the Urethra on the bottom surface of the penis. If the bottom part is extended too far one cannot tighten the device properly.

Figure 1.   The bottom is set at 3 and therefore the device has a moderate loop that will  apply pressure to the urethra

    

Figure 2.  PMT has a TURBO PAD available which is now the updated design .  The TURBO PAD increases the thickness of the bottom pad compressing directly on the urethra and is therefore sometimes helpful when no other measure helps. This image shows the TURBO PAD extra thickness and enlarged surface area designed to give more comfort.

To Purchase Pacey Cuff : go to Amazon or PaceyCuff.com  for special discounts! Be sure to give a positive 5 star review so that other men will be able to have the benefits of Urethral Compression Device control.

Freedom from bondage of Incontinence - PaceyCuff.com

Once you have control of your incontinence !

Enjoy your Grandchildren!

Do that European Bike Trip

Get Back to Skiing

Continue playing in the Folk Band

Go to PaceyCuff.com for purchase!

Exciting New Treatment Strategy for some Advancing Prostate Cancers

paceycuff.com

Q. What do Your Doctors Recommend when you have Had Radiation or Surgery and your PSA continues to rapidly Rise in Spite of AntiAndrogen Therapy?

A. Not so much .

         Exciting new research has changed all of this!

Now a new Treatment path has been shown to provide 20 or more months of metastasis free survival time than previous watchful waiting. 

Remember this is a specific group of patients but it is not a small group that can now be substantially helped. ( currently 100,000 in the USA).

Spartan Trial       1207 patients      (Janssen Biotech)

Oral androgen receptor inhibitor-Apalutamide.

The metastasis free survival was 40 months compared to 26 months for the control group treated with antiandrogen therapy alone.

Prosper Trial              (Pfizer group)

Earlier oral androgen receptor inhibitor-Enzalutamide.  

The metastasis free survival was 36.6 months compared to 14.7 months for the control group treated with antiandrogen therapy alone.

The 2 trials will be reported this week at the Genitourinary Cancer Symposium 2018 in San Francisco where it is expected these drugs will propel a major change in therapy.  

Both trials were done on men post treatment who had PSA double within 10 months time span indicating active cancer cell development.

The  unanswered question of which drug is superior must remain conjecture until a proper head to head comparison is carried out.

          PaceyCuff.com for incontinence problems